Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mogens Vyberg

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Peptides|December 22, 2025
Distinct and complementary metabolic effects of GLP-1 and glucagon receptor agonism in diet-induced obese miceMarie Winther-Sørensen, Christine Rasmussen, Samuel A J Trammell, et al.
Scientific Reports|December 28, 2023
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosisHenrik H Hansen, Susanne Pors, Maja W Andersen, et al.
Clinical and Translational Science|February 10, 2022
Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASHMathias B Møllerhøj, Sanne S Veidal, Kirstine Tølbøl Thrane, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 5, 2014
Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert CommitteeEmina E Torlakovic, Søren Nielsen, Glenn Francis, et al.
Plos One|June 9, 2025
The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver diseaseJosephine Grandt, Christian D Johansen, Anne-Sofie H Jensen, et al.
Physiological Reports|April 20, 2023
Postprandial dysfunction in fatty liver diseaseJosephine Grandt, Anne-Sofie H Jensen, Mikkel P Werge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 30, 2022
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation StudyAmber Louw, Vasiliki Panou, Weronika Maria Szejniuk, et al.
American Journal of Clinical Pathology|February 16, 2010
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests, Emina Emilia Torlakovic, Robert Riddell, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 7, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry BiomarkersCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC LaboratoriesEmina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Peptides|December 22, 2025
Distinct and complementary metabolic effects of GLP-1 and glucagon receptor agonism in diet-induced obese miceMarie Winther-Sørensen, Christine Rasmussen, Samuel A J Trammell, et al.
Scientific Reports|December 28, 2023
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosisHenrik H Hansen, Susanne Pors, Maja W Andersen, et al.
Clinical and Translational Science|February 10, 2022
Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASHMathias B Møllerhøj, Sanne S Veidal, Kirstine Tølbøl Thrane, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 5, 2014
Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert CommitteeEmina E Torlakovic, Søren Nielsen, Glenn Francis, et al.
Plos One|June 9, 2025
The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver diseaseJosephine Grandt, Christian D Johansen, Anne-Sofie H Jensen, et al.
Physiological Reports|April 20, 2023
Postprandial dysfunction in fatty liver diseaseJosephine Grandt, Anne-Sofie H Jensen, Mikkel P Werge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 30, 2022
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation StudyAmber Louw, Vasiliki Panou, Weronika Maria Szejniuk, et al.
American Journal of Clinical Pathology|February 16, 2010
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests, Emina Emilia Torlakovic, Robert Riddell, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 7, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry BiomarkersCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC LaboratoriesEmina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
Pageof 11